Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) sees significant drop in short-term interest

0

Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating) saw a significant decline in short-term interest in April. As of April 30, there was short interest totaling 723,800 shares, down 31.1% from the April 15 total of 1,050,000 shares. Based on an average daily volume of 524,900 shares, the day-to-cover ratio is currently 1.4 days.

A number of institutional investors and hedge funds have recently changed their positions in the stock. PEAK6 Investments LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 640.9% in Q1. PEAK6 Investments LLC now owns 15,686 shares of the company worth $528,000 after acquiring an additional 18,586 shares during the period. Northern Trust Corp increased its stake in Fresenius Medical Care AG & Co. KGaA by 9.5% in Q1. Northern Trust Corp now owns 166,470 shares of the company worth $5,607,000 after acquiring an additional 14,445 shares during the period. Interchange Capital Partners LLC bought a new position in Fresenius Medical Care AG & Co. KGaA in Q1 worth $229,000. Clearbridge Investments LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 29.0% in the 1st quarter. Clearbridge Investments LLC now owns 229,672 shares of the company worth $7,735,000 after acquiring an additional 51,585 shares during the period. Finally, Freestone Capital Holdings LLC bought a new position in Fresenius Medical Care AG & Co. KGaA in Q1 worth $390,000. Hedge funds and other institutional investors own 4.73% of the company’s shares.

FMS has been the subject of a number of research analyst reports. Jefferies Financial Group downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “hold” rating to an “underperform” rating and lowered its price target for the company from $32.40 to $30.30 in a research note from Friday, February 11. Societe Generale lowered its price target on shares of Fresenius Medical Care AG & Co. KGaA from €61.00 ($64.21) to €57.00 ($60.00) in a Friday 25 research note. february. Credit Suisse Group lowered its price target on shares of Fresenius Medical Care AG & Co. KGaA from €66.00 ($69.47) to €61.00 ($64.21) in a research note from the Tuesday, March 1. JPMorgan Chase & Co. raised its price target on shares of Fresenius Medical Care AG & Co. KGaA from €48.70 ($51.26) to €51.00 ($53.68) and assigned the company an “underweight” rating in a Thursday, May 5 research note. . To finish, StockNews.com alleged hedging of shares of Fresenius Medical Care AG & Co. KGaA in a research note from Tuesday, May 10. They set a “buy” rating on the stock. Two investment analysts have assigned the stock a sell rating, seven have issued a hold rating and four have assigned the stock a buy rating. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $51.63.

Shares of New York Stock Exchange: FMS traded at $0.41 during Friday’s trading, reaching $29.21. 486,000 shares of the company have been traded, against an average volume of 409,242. The company has a fifty-day simple moving average of $32.46 and a 200-day simple moving average of $32.47. The company has a market capitalization of $17.12 billion, a P/E ratio of 16.69, a price-to-earnings growth ratio of 1.18 and a beta of 1.17. Fresenius Medical Care AG & Co. KGaA has a 1 year minimum of $28.75 and a 1 year maximum of $42.45. The company has a quick ratio of 0.93, a current ratio of 1.26 and a leverage ratio of 0.51.

Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating) last reported results on Wednesday, May 4. The company reported earnings per share (EPS) of $0.38 for the quarter, beating consensus analyst estimates of $0.30 by $0.08. The company posted revenue of $5.10 billion in the quarter, against analyst estimates of $4.97 billion. Fresenius Medical Care AG & Co. KGaA achieved a net margin of 4.91% and a return on equity of 6.99%. As a group, research analysts expect Fresenius Medical Care AG & Co. KGaA to post EPS of 1.99 for the current year.

The company also recently declared an annual dividend, which will be paid on Friday, May 27. Shareholders of record on Monday, May 16 will receive a dividend of $0.7093 per share. The ex-dividend date is Friday, May 13. This represents a dividend yield of 3.4%. The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is currently 32.57%.

About Fresenius Medical Care AG & Co. KGaA (Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Featured articles



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.